Global Diabetes 2019 aims to gather the Researchers, principal investigators, experts and researchers working under academia and healthcare and pharmaceutical industry, Business Delegates, Scientists and students across the globe to provide an international forum for the dissemination of original research results, new ideas, and practical development experiences. We hope that you will grasp this academic occasion to revitalize the enduring connections and flash with new peers around the globe.
Meet the Global Inspiring Experts and Speakers at our Global Diabetes 2019 to talk about on new advances in the field of medical and engineering to improve health and treatment and additional innovations. Global Diabetes 2019 , not just make a phase to exchange estimations to the enormous social occasion of individuals, yet also endeavor to spread concentrated and research advances in the clinical, definite and physiological parts of medicinal and designing. It happens to be more feasible for everyone to put in the photograph with novel research and to perceive the degree and noteworthiness of specific research run in the field of therapeutic and designing.
Allied Academies is a well-developed and presumed publisher which started distributing in the year 1994. At first, the convergence of the social occasion was to make gatherings with distribution and publications of articles in the area of Business and Management, with time the distributor expanded the subject degree and by focusing on different branches of learning.
Allied Academies Organizes CPD Accredited Global Diabetes, Obesity, Health and Medicare Expo along with 300+ Conferences across USA, Europe & Asia every year with support from 1000 more scientific societies and Publishes 400+ Open access journals which contain over 30000 eminent personalities as editorial board members.
We invite you to join us at the CPD Accredited Global Diabetes, Obesity, Health and Medicare Expo, where you will be sure to have a meaningful experience with scholars from around the world. All members of the CPD Accredited Global Diabetes, Obesity, Health and Medicare Expo, organizing committee look forward to meeting you in Bangkok, Thailand on September 2-3, 2019.
Scientific Session 1: Diabetes
Diabetes is also a common chronic illness that imposes right smart demands on the individual tending system. Type 1 diabetes, type 2 diabetes and gestational diabetes are the kinds of diabetes. Type 1 diabetes outcomes from the auto-immune destruction of the insulin producing beta cells in the pancreas. Type 1 diabetes can be depicted from type 2 diabetes by auto-antibody testing and C-peptide test. Type 1 diabetes represents 100% of all diabetic cases. Type 2 diabetes may be a disorder that's defined by internal secretion resistance and relative absence of internal secretion. Roughly ninetieth (90 %) of patients suffer from kind two diabetes. Sudden raise within the blood glucose levels due to placental hormones, during pregnancy leads gestational diabetes. In addition to this, type 3 diabetes is represented by the insulin resistance to brain which leads to Alzheimer’s disease.
- Type 1diabetes
- Type 2 diabetes
- Gestational Diabetes Mellitus
- Risk factors for Type 2 Diabetes
- Glucose Metabolism
- Novel Biomarkers for Type 2 Diabetes
- Pathophysiology of Diabetes
- Cell Therapy for Diabetes
- Surgery & Transplantation
Scientific Session 2: Obesity
Obesity refers to high body fat. It is different from overweight. Obesity increases the risk of diabetes, stroke, other cardiovascular diseases, cancer and arthritis. Obesity occurs due to intake of high fat foods, decreased or no physical activity, genetic makeup, smoking, dysfunction of metabolic activity, due to lack of sleep, medications that make patients put on weight and many more. Metabolic and bariatric surgeries are usually performed to control the diabetes in obese people. Obesity is a therapeutic condition in which abundance muscle to fat ratio has collected to the degree that it might negatively affect the health. Individuals are large thought to be hefty when their body mass index (BMI), have estimation got by isolating a man's weight by the square of the individual's stature. If it is more than 30 kg/m2, with the range 25– 30 kg/m2 characterized as overweight. Some East Asian nations utilize bring down qualities. Obesity improves the probability of different diseases and conditions, especially it may cause.
- Eating Disorders of Obesity
- Etiology of obesity
- Juvenile Obesity
- Teenage Obesity
- Obesity and Pregnancy
- Obesity in Men
- Genetics of Obesity
- Obesity and Cancer
- Obesity in Animals
- Obesity in Women
- Obesity and Weight Management
- Bariatric therapy
- Epidemiology of Obesity
- New Directions in treatment of Obesity
- Insights on Nutritional Findings and Eating Disorders
- Anti-Obesity Drugs
- Yoga and Naturopathy
- Current research on Obesity
- Physical Activity
Scientific Session 3: Diabetic Nutrition & Physical Fitness
Diet and physical fitness are crucial parts of a sound way of life when you have diabetes. Along-side different advantages, following a healthy balanced diet and being dynamic can enable you to keep your blood glucose level in your objective range. To deal with your blood glucose level, you must adjust with what you eat and drink along with physical movement and medications. The quality and quantity of food that you eat, and when you eat are extremely, important in keeping your blood glucose level in the range that your healthcare professional suggests.
The nutrition rich food contains all the essential components can help us stay healthy even before and after suspected by the disorder
- Exercise for diabetics
- Diet for Diabetics
- Nutrition for Diabetics
- Protein intake and Diabetes
- Food combinations and diabetes
- Lifestyle Intervention and Diabetes Prevention
- Statistics About Diabetes
Scientific Session 4: Endocrinology
Endocrinology is a branch of biology and medicine dealing with the endocrine system, its diseases, and its specific secretions known as hormones. it is also involved with the integration of developmental events proliferation, growth, and differentiation, and the psychological or behavioral activities of metabolism, growth and development, tissue function, respiration, sleep, digestion, excretion, mood, stress, lactation, movement, reproduction, and sensory perception caused by hormones.
- Endocrinology Disorders
- Pathophysiology of Endocrine Glands and Hormones
- Advanced Treatment and Technologies in Endocrinology
- Thyroid disorders
Scientific Session 5: Diabetes in Health Care
Social insurance modification calls for new ways to deal with diabetes mind conveyance and more noteworthy accentuation on averting diabetes and its intricacy. Medical services are the upkeep or change of wellbeing by means of the avoidance, analysis, and treatment of malady, sickness, damage and other physical and mental hindrances in people. Then, social insurance is conveyed by wellbeing experts (suppliers or professionals) in unified wellbeing callings, doctors, doctor partners, dentistry, maternity care, nursing, pharmaceutical, optometry, audiology, drug store, brain science, and other wellbeing callings. Essential care is frequently utilized as the term for the social insurance administrations which assume a part of the nearby cluster. It can be given in various settings. Secondary care incorporates intense care: fundamental treatment for a brief time frame for a brief yet genuine sickness, other wellbeing condition or damage. For example, in a doctor's facility crisis division. Otherwise it incorporates gifted participation amid labor, escalated care, and medicinal imaging administrations. There is prodigious vitality around new advancement and new businesses endeavoring to take care of different issues within the medicinal services framework. So, that Diabetes mind has gradually been developing from a supplier overwhelmed way to deal with a cooperative exertion between the human services supplier and patient.
Scientific Session 6: Gestational Diabetes
Gestational diabetes happens only during pregnancy. This is because, during pregnancy, the placenta makes hormones which can leads to high sugar levels in the blood. Generally, to normalize the high blood sugar levels, the pancreas should produce’s enough insulin. But, if the insulin production is deficient or improper, then it could lead to high sugar levels in the blood of a pregnant, therefore it leads to gestational diabetes. Then the Risk factors include family history of having diabetes, overweight before getting pregnant, PCOS, case history of gestational diabetes etc. It can be treated with a low carbohydrate diet, physical fitness and insulin injections. Gestational diabetes is high blood sugar that develops during pregnancy and usually disappears after giving birth. It can occur at any stage of the pregnancy, but it is more common in the second half. It occurs if a women’s body cannot produce enough insulin to meet the extra need in during pregnancy. Any women can develop gestational diabetes during pregnancy but the increase in risk if the pregnant women’s body mass index is above 30, she previously had a baby who weighted above 4.5 kg or more than that, she had gestational diabetes during previous pregnancy. Some women may develop symptoms if their blood sugar level gets too high, hyper glycemia such as increased thirst, need to pee more than usual, a dry mouth and tiredness. Gestational diabetes in a long-term effect which can lead to type 2 diabetes.
- Pre-mature birth
Scientific Session 7: Alternative therapies for Diabetes
Alternative therapies are often well-defined as a "cluster of varied therapeutic and health care arrangements, practices, and medicines that aren't presently measured to be a part of predictable medicine”. Complementary medicine is used with certain therapy, whereas alternative medicine is used rather than typical medicine. Although few therapies may be useful, others are not therefore helpful or maybe harmful. Contrary reactions of the many therapies are not known because patients with diabetes usually take various diabetes medications; there occurs budding for herbal medicine and herb dietary habit supplement interactions, resulting in contrary events.
- Stem Cell Therapy for Diabetes Type 1 and Type 2
- Chemotherapy Effects in Diabetes
- Herbal Medicine
- Ayurvedic Medicine
- Traditional Medicine
- Mind-Body & Yoga Therapies
- Insulin therapies
- Non-insulin therapies
- Pharmacological therapies
- Chinese Medical Therapies
- Fluid & electrolyte therapy
- Cellular-based therapy
- Hormonal Therapy
- Gene therapy in diabetes
- Pancreatic Enzyme Replacement Therapy
- Proton / Laser Therapy
- Mind-Body & Yoga Therapies
- Pharmacological therapies
- Ozone-Oxygen Therapies
- Diabetes Statin therapy
- Nutritional therapies
- Bariatric surgery and conventional therapy
- Drug therapies
- Fluid & electrolyte therapy for Endocrine disorders
- Nano technology for Diabetes
- Over the counter & prescription medications
Scientific Session 8: Diabetes and Its Complication
Long-standing complications of diabetes grow progressively. Number of years having diabetes is directly proportional to the higher risk of complications. At last health issues quicken the venomous effects of diabetes which include smoking, obesity, higher diabetes cholesterol levels, high blood pressure, and lack of regular exercise. The best seer of type 2 diabetes is obesity and weightless. And also, they are different Complications for Diabetes.
- Diabetic cardiomyopathy
- Diabetic Nephropathy
- Diabetic Neuropathy
- Diabetic Retinopathy
- Diabetic Coma
- Diabetes Dermatology
- Diabetes Pediatrics
- Diabetes and Oral health
- Diabetes and Colo-Rectal Cancer
- Diabetic/Glycogenic Hepatopathy
- Diabetic Bulla
- Diabetic Wounds
Scientific Session 9: Diabetic Foot Ulcer
Foot ulcers are also a common complication of poorly controlled diabetes, forming as a result of skin tissue breaking down and exposing the layers underneath. They are most commonly present under your big toes and the balls of your feet, and they can affect your feet down to the bones. Unusual swelling, irritation, redness, and odours from one or both feet are also common early symptoms of a foot ulcer. The most visible sign of a serious foot ulcer is black tissue (called eschar) surrounding to the ulcer. These form because an absence of healthy blood flows to the area around the ulcer. Diabetic ulcers are most commonly caused by poor circulation, high blood sugar (hyper glycaemia), nerve damage, irritated or wounded feet. Diabetic foot infections frequently cause morbidity, hospitalization, and amputations. Then the Gram-positive cocci, especially staphylococci and also streptococci are the predominant pathogens. And also the Chronic or previously treated wounds often yield several microbes on culture including gram-negative bacilli and anaerobes. Selecting an appropriate antimicrobial therapy for diabetic foot infections requires knowledge of the likely etiologic agents. Various skin disorders and environmental exposures, as well as recent antibiotic therapy, can alter the colonizing flora of skin wounds.
Scientific Session 10: Biomarkers: Diabetes, Endocrinology and obesity
Molecular Biomarkers is demarcated as a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacological responses to a pharmaceutical intervention. Biomarkers play an important part in leading clinical trials and treating patients. Advances in molecular diagnostics facilitate medical professionals make knowledgeable, scientifically valid choices. Additional well-organized discovery and usage of biomarkers within the growth of anti-diabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macro vascular complications. Procedural improvements from different fields, especially cancer, are beginning to show the method towards better models of diabetes pathogenesis and molecular biomarker discovery. Diabetes is a major lifestyle disease and a leading cause of cardiovascular diseases. It is necessary to identify the potential of biomarkers associated with diabetes for the early detection of the disease and its proper management. Elevated blood pressure, elevated triglycerides, and low HDL cholesterol are some of the common biomarkers of diabetes, adiponectin, C-reactive protein (CRP), interleukin-2 receptor, ferritin A being the other counterparts. Apart from these available and the known biomarkers, other potential biomarkers are also being searched and reported by researchers.
- Diabetes Mellitus: RBS, FBS, HbA1c, Retinal assessments
- Hypertension: BP, HR, Angiotensin I, II, Plasma Renin, Aldosterone
- Heart Failure: PRO-BNP
- Asthma/COPD: PFTs, Leukotrienes
- Cardiac Ischemia: Troponins, Myoglobins
- Endocrine Biomarkers: LCN2 (NGAL), HAVCR1 (KIM-1), HAMP (Hepcidin), GIP, PDGFB, PGF (PLGF), FLT1 (VEGFR1), FGF23, PYY, CCL2 (MCP1)
Scientific Session 11: Diabetes Clinical research and Case studies
A Clinical trial is an approach to precisely test another medication or gadget in patients before it is supported by the FDA to be utilized in public. Clinical trials are important and critical step in having the capacity to have new medications for diabetes and other varied conditions. A case study is a methodology and a strategy that investigates a phenomenon with its real-life context. Case studies and clinical trials are used to develop or access the quality of the medications being developed. The clinical case report, which describes and analyses the diagnosis and management of one or two patients is the first line of evidence in health care. It is a powerful tool to disseminate information on unusual clinical syndromes, unusual side effects to therapy or response to treatment and disease associations. Collection of reports of patients suffering from various disorders or diseases that are commonly seen in a diabetes and endocrine unit. It may provide a comprehensive discussion on the diagnosis and management of each patient. There are many diseases which are included under case reports including Cushing's Syndrome , diabetes insipidus, acromegaly, osteoporosis, adrenal carcinoma, Turner's syndrome, hypopituitarism, viral thyroiditis, Nelson's syndrome, juvenile thyrotoxicosis, pancreatic tumor, diabetic pregnancy, multiple endocrine neoplasia, gonadal dysgenesis, congenital adrenal hyperplasia, and polycystic ovary syndrome. It provides valuable resource for those who takes training in clinical medicine or for those who pursuing a career in endocrinology and diabetes.
- Clinical diagnosis and laboratory tests
- Diabetes, Pre-diabetes and Metabolic Syndrome
- Clinical trials on animal models
- Novel research and treatment strategies on diabetes
- Clinical case reports and clinical endocrinology practices
- Novel Paradigms in Diabetic Complications
Scientific Session 12: Diagnosis of Diabetes
Diabetes can be analysed based on either plasma glucose criteria or A1C criteria. Early in the disease diabetes shows no symptoms.so, that blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnostic in diabetes involve taking blood at a healthcare facility centre or commercial diagnostic centre and sending the sample to the lab for examination. To ensure that the test results are accurate in lab for study of blood are required. Glucose calculating devices used in a health care provider’s office, such as finger-stick devices, are not precise enough for analysis but may be used as a rapid indicator for high blood sugar. Such area of research are highly discussed in ADA annual meetings and ADA sessions.
- A1C test
- Random plasma aldohexose (RPG) check
- Intensive insulin management and pump therapy
- Insulin Pens and novel Insulin delivery techniques
- Tear glucose monitoring contact lenses
- Continuous glucose monitoring (CGM)/ Blood Glucose Meters
- New Insulin Analogues
- Artificial pancreas Fasting plasma aldohexose (FPG) check.
- Blood glucose monitoring: Glucose pumps & sensors
- Intravenous blood glucose monitoring systems
- Insulin dose calculation software
- Flash Glucose Monitoring.
- New insulin delivery systems: Inhaled, transdermal patches, and implanted devices
- The Future: the Artificial Beta Cell
Scientific Session 13: Advanced Technologies & Treatments for Diabetes
The Advanced technologies & treatments for diabetes are many in now a days according the region and the specialty of the equipment availability. In Current Research in diabetes is focusing on developing Implantable insulin pumps which introduces Insulin pump therapy, Artificial pancreas, invasive and non-invasive glucose sensors, disruption of fat metabolism, Insulin Pens, insulin delivery systems like inhaled, transdermal and implantable devices, Bariatric surgery and Conventional therapeutic approaches. The developed countries had an huge impact on the advanced technologies and treatment for diabetes. The modern and easy way of treating diabetes is like insulin pens, insulin inhaled through conventional techniques. The transplantation is done through by means of organ transplantation, donor transplantation, tissue transplantation. These are the some of the advanced technologies & treatment of diabetes in their core. The Advanced technologies & treatments for diabetes are many according to the region and the specialty of the equipment availability. Every year creative minds and companies introduce a crop of high tech devices, Advancement of New Drug/Biomarker Discovery and Treatments.
- Flash Glucose Monitoring
- Continuous Glucose Monitoring
- Insulin Pumps
- Bionic Pancreas
- Novo Pen Echo
- Smart Sox
- Glucose Buddy
- Short activity insulin
- Insulin mixtures
- Ultra-long acting insulin
Scientific Session 14: Global Diabetes Market
Diabetes trade directs to the 11th largest therapeutic and diagnostic companies producing diabetes related merchandises or those who involved with to take diabetes cure to next level. Diabetes is an major issue in the UK, and as such a large healthcare and medical industry has come up like mushroom around it. Aspects such as growing number of diabetic patients across BRIC countries, increasing the study on diabetes, and also increasing the international research collaborations are lashing the growth of the this market. In the European Region there are about 60 million people leaving with diabetes, or about 10.3% of men and 9.6% of women aged 25 years and over. Occurrence of diabetes is growing among all the ages in the, typically due to escalations in overweight and obesity, unhealthy diet and less of physical activity.
Scientific Session 15:
Diabetic medicare covers the fasting blood glucose test that is a diabetes screening. Medicare covers 2 diabetes screenings each year for beneficiaries WHO are at high risk for diabetes. High risk factors for diabetes include: high blood pressure, history of abnormal steroid and lipid levels, obesity, or a history of high glucose. If this disorder runs in your family, you additionally may also needs regular diabetes testing. Diabetic medicare may include Therapeutic shoe, glucose control solution, Lancets or Lancet devices as prescribed by your doctor.
Abstract Submission &Registration
Allied Academies, the largest Open Access Publisher and Scientific Events Organizer, publishing more than 400 Open Access journals and organizing more than 300 scientific events per year offers membership to students. CPD Accredited Global Diabetes, Obesity, Health and Medicare Expo Committee would like to invite speakers to submit their research for inclusion in the Global Diabetes 2019 scientific program.
The Young Researchers Forum offers young researchers the possibility to meet and discuss research topics and methodologies, share and develop ideas, learn from each other and gain knowledge from senior researchers.
to Register: http://globaldiabetes.alliedacademies.com/registration
Thailand, with a population of 68 million, is Southeast Asia’s third most populous country after Indonesia (256 million) and the Philippines (104 million). As the country continues to undergo economic growth and demographic changes, Thailand’s pharmaceutical market presents numerous opportunities for foreign pharmaceutical companies.
According to the International Monetary Fund (IMF), Thailand’s GDP based on Purchasing Power Parity (PPP) exceeded $1.1 trillion dollars in 2016, making Thailand the second largest economy in Southeast Asia after Indonesia, which has a GDP (PPP) of $3 trillion. In 2016, Thailand’s GDP grew by 3.2%, compared to 1.6% in the US and 2% in the European Union (IMF). The Asian Development Bank predicts Thailand’s GDP will grow 3.5% and 3.6% in 2017 and 2018, respectively.
Thailand imported over $2.2 billion in pharmaceuticals in 2016, a considerable increase from $1.8 billion just two years ago. In 2016, over 65% of Thailand’s pharmaceutical imports came from the United States, Europe, and Canada. Germany was the largest pharmaceutical exporter to Thailand, followed by the US, France, then Switzerland. The Thai pharmaceutical market was valued at over $5 billion in 2016, making it the second largest market in Southeast Asia. The value of Thailand’s pharmaceutical market is expected to double by 2020. Pharmaceutical sales per-capita are also predicted to grow from $75 in 2016 to $125 by 2024.
Hospitals purchase over two-thirds of all pharmaceuticals sold in Thailand and primarily purchase generics and prescription pharmaceuticals, compared to drugstores which sell over-the-counter (OTC) products. Thailand has one of the largest medical tourism markets in the world, and over two million foreign patients have traveled to the country annually since 2013. The continued growth of Thailand’s medical tourism industry has further increased the demand for pharmaceuticals.